Errarum: MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4 (Int J Oncol (2015) 47 (1594‑1602) DOI : 10.3892/ijo.2015.3114);MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4

International Journal of Oncology

Volumn 47, Issue 4, 2015, Pages 1594-1602

  Jin, Ying ^a   Zhao, Min ^a   Xie, Qian ^a   Zhang, Hongyan ^a   Wang, Qing ^a   Ma, Qingjie ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Breast cancer; MiR 338 3p; Proliferation; SOX4

Indexed keywords

MICRORNA; MICRORNA 338 3P; TRANSCRIPTION FACTOR SOX4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1; MIRN338 MICRORNA, HUMAN; SMALL INTERFERING RNA; SOX4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LINE; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; AGED; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MIDDLE AGED; PATHOLOGY; TUMOR INVASION; XENOGRAFT;

ADULT; AGED; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SOXC TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84940987985     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2024.5609     Document Type: Erratum

References (40)

1. DeSantis C, Ma J, Bryan L and Jemal A: Breast cancer statistics, 2013. CA Cancer J Clin 64: 52-62, 2014.
2. Hong W and Dong E: The past, present and future of breast cancer research in China. Cancer Lett 351: 1-5, 2014.
3. Berse B and Lynch JA: Molecular diagnostic testing in breast cancer. Semin Oncol Nurs 31: 108-121, 2015.
4. Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379, 2010.
5. Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840, 2010.
6. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
7. McManus MT: MicroRNAs and cancer. Semin Cancer Biol 13: 253-258, 2003.
8. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
9. Tang J, Ahmad A and Sarkar FH: The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 13: 13414-13437, 2012.
10. Christodoulatos GS and Dalamaga M: Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol 5: 71-81, 2014.
11. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, et al: Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7: e29770, 2012.
12. Le Quesne J and Caldas C: Micro-RNAs and breast cancer. Mol Oncol 4: 230-241, 2010.
13. Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, Bi J, Zhang LJ, Su Q and Zeng WT: miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 225: 463-472, 2011.
14. Fu X, Tan D, Hou Z, Hu Z, Liu G, Ouyang Y and Liu F: The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation. PLoS One 7: e43204, 2012.
15. Chen X, Pan M, Han L, Lu H, Hao X and Dong Q: miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Lett 587: 3729-3737, 2013.
16. Wen C, Liu X, Ma H, Zhang W and Li H: miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2. Int J Oncol 46: 2277-2285, 2015.
17. Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C and Lui WO: MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130: 2062-2070, 2010.
18. Li P, Chen X, Su L, Li C, Zhi Q, Yu B, Sheng H, Wang J, Feng R, Cai Q, et al: Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One 8: e66782, 2013.
19. Guo B, Liu L, Yao J, Ma R, Chang D, Li Z, Song T and Huang C: miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Mol Cancer Res 12: 313-321, 2014.
20. Sun K, Su G, Deng H, Dong J, Lei S and Li G: Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma. Chin Med J (Engl) 127: 1884-1890, 2014.
21. Sun K, Deng HJ, Lei ST, Dong JQ and Li GX: miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol 19: 2197-2207, 2013.
22. Wang L and Wang J: MicroRNA-mediated breast cancer metastasis: From primary site to distant organs. Oncogene 31: 2499-2511, 2012.
23. Kusama M, Kaise H, Nakayama S, Ohta D, Aoki T and Koyanagi Y: A case of breast cancer patient of CAF (cyclophosphamide, adriamycin, 5-fluorouracil) resistant lung metastasis with remarkable response to reverse drug-resistance by toremifene. Gan To Kagaku Ryoho 26: 1171-1175, 1999 (In Japanese).
24. Tang J, Ahmad A and Sarkar FH: The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 13: 13414-13437, 2012.
25. Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang C, Wu S, Yu D, Huang Z, Liu F, et al: MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep 5: 9995, 2015.
26. Ahmad A, Ginnebaugh KR, Sethi S, Chen W, Ali R, Mittal S and Sarkar FH: miR-20b is up-regulated in brain metastases from primary breast cancers. Oncotarget 6: 12188-12195, 2015.
27. Li W, Zhai L, Zhao C and Lv S: MiR-153 inhibits epithelialmesenchymal transition by targeting metadherin in human breast cancer. Breast Cancer Res Treat 150: 501-509, 2015.
28. Yi B, Piazza GA, Su X and Xi Y: MicroRNA and cancer chemoprevention. Cancer Prev Res (Phila) 6: 401-409, 2013.
29. Vervoort SJ, Loureno AR, van Boxtel R and Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal markers during mammary cell epithelial to mesenchymal transition. PLoS One 8: e53238, 2013.
30. Vervoort SJ, van Boxtel R and Coffer PJ: The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: Friend or foe? Oncogene 32: 3397-3409, 2013.
31. Bowles J, Schepers G and Koopman P: Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227: 239-255, 2000.
32. Song GD, Sun Y, Shen H and Li W: SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients. Tumour Biol: Jan 16, 2015 (Epub ahead of print] 2015.
33. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM: Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 101: 9309-9314, 2004.
34. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML and Moreno CS: Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 69: 709-717, 2009.
35. Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van Nimwegen E and Christofori G: Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell 23: 768-783, 2013.
36. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152, 2008.
37. Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA and Andl CD: SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells. Mol Cancer 14: 24, 2015.
38. Yu X, Song H, Xia T, Han S, Xiao B, Luo L, Xi Y and Guo J: Growth inhibitory effects of three miR-129 family members on gastric cancer. Gene 532: 87-93, 2013.
39. Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M, Quan ZX and Chen J: MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4. Cell Physiol Biochem 34: 2180-2188, 2014.
40. Yeh YM, Chuang CM, Chao KC and Wang LH: MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer 133: 867-878, 2013.